What if we could add not just years to life but life to years?Join me at the Global Longevity Summit this October. Use code BEYONDTOMORROW for 10% off your ticket: https://www.a4m.com/global-longevity-summit-2025.htmlIn this episode, I’m sitting down with Dr. Mehmood Khan, CEO of Hevolution Foundation, a global initiative pledging up to $1 billion per year to advance longevity science. Dr. Khan shares how his team is tackling one of humanity’s greatest challenges: helping everyone stay healthy for as long as possible.From the economics of an aging world to cutting-edge therapies like senolytics, epigenome modulation, and AI-driven discovery, Dr. Khan explains why healthspan - not just lifespan is the real moonshot. He reveals how Hevolution funds hundreds of research programs worldwide, why the Gulf region faces unique aging patterns, and how breakthroughs in the next decade could transform medicine, society, and the global economy.Whether you’re a biotech investor, health enthusiast, or simply curious about living better for longer, this conversation delivers science, strategy, and a hopeful vision of the future.📌 What You’ll Learn in This EpisodeWhy healthspan matters more than raw lifespanThe $1 billion annual commitment behind Hevolution FoundationHow aging challenges economies, families, and global stabilityGenetic vs. lifestyle factors in accelerated agingPromising therapeutics: senolytics, mTOR modulation, epigenome reprogrammingHow AI accelerates longevity researchThe TAME trial and metformin’s potentialScaling breakthroughs so everyone benefitsThe next decade of longevity science - what’s realistic and what’s hype⏱️ Timestamps 00:00 – Opening & mission to expand healthy lifespan 01:04 – Global Longevity Summit & Hevolution’s vision 02:24 – Why “healthspan” is the true goal 05:09 – Dr. Khan’s early career and medical insights 07:17 – Building a foundation to invest $1 billion annually 09:55 – Saudi Arabia’s long-term approach to longevity 12:49 – Why some populations age faster 16:27 – Economic and social costs of an aging world 22:42 – How to spark a global movement for healthspan 28:21 – Balancing visionary goals with practical milestones 32:59 – Funding breakthroughs - senolytics, TAME trial, more 38:32 – Targeting senescent cells in real-world therapies 44:01 – Making advanced treatments affordable for all 47:33 – The most promising areas: mTOR, epigenome, gene therapy 52:07 – Predictions for 2030 and realistic healthspan gains 55:28 – The role of AI in longevity research 1:00:42 – Why Dr. Khan is optimistic about the future 1:03:09 – Closing thoughts and next-episode preview

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related